Código QR

The Mechanism and Potential Therapeutic Effects of Cyclosporin, Cyclophilin, Probiotics and Syndecan-1 in an Animal Model of Inflammatory Bowel Disease

<b>Background:</b> Inflammatory bowel diseases (IBDs) have several treatment modalities including immunoregulators, like cyclosporine A, an immunosuppressant that interacts with cytoplasmic cyclophilin A, and probiotics. <b>Aims:</b> This study explored and compared the possible role of syndecan-1 i...

Descrición completa

Gardado en:
Principais autores: Laura Dosh, Francesca Rappa, Abdo Jurjus, Gaelle Karam, Roaa Lezeik, Jad El Masri, Fabio Bucchieri, Angelo Leone, Rosalyn Jurjus
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2024-01-01
Series:Pharmaceutics
Assuntos:
cyclosporine A
cyclophilin A
probiotics
IBD
inflammation
syndecan-1
Acceso en liña:https://www.mdpi.com/1999-4923/16/1/130
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares